Cardiovascular and Metabolic Disorders

Latest News

Highest CV Risk Observed Among Patients Not Adherent to Low-Intensity Statin Therapy

By

Brandon May

Improving adherence with high-intensity lipid lowering therapies could greatly reduce CVD risk.

Statins in Patients Older Than 75: A Meta-Analysis of 28 Controlled Trials

By

Endocrinology Advisor Contributing Writer

Researchers conducted a meta-analysis of data from all large statin trials to especially compare the effects of statin therapy on persons older than age 75.

Suboptimal Triglyceride Levels Common Among US Adults

By

Hannah Dellabella

Researchers evaluated the prevalence of elevated triglyceride levels in adults with and without statin use and the related 10-year predicted risk for atherosclerotic cardiovascular disease.

DPP-4 Inhibition Potentially Reduces Atherogenesis in Some People Living With HIV

By

Roxanne Nelson, BSN, RN

Treatment with sitagliptin had no effect on soluble CD14 when given to participants with virally suppressed HIV infection.

Aspirin Reduces CV Event Risk in Individuals Without Cardiovascular Disease

By

Brandon May

The use of aspirin was associated with a lower risk for cardiovascular events in individuals without cardiovascular disease.

Higher Exposure to CVD Risk Factors in Women vs Men Who Have Diabetes

By

Roxanne Nelson, BSN, RN

Compared with men, women who have diabetes experience greater changes in the cumulative burden of cardiovascular risk factors from young to middle-age adulthood.

Lipoprotein(a) as Risk Factor in Heterozygous Familial Hypercholesterolemia

By

Endocrinology Advisor Contributing Writer

Researchers examined whether lipoprotein(a) cholesterol life-years can effectively measure cumulative risk for atherosclerotic cardiovascular disease and questioned whether this metric may apply to the incidence of aortic valve calcification.

Novel Lipid Biomarker HDL3-C Predicts Severity of Coronary Artery Disease

By

Endocrinology Advisor Contributing Writer

Investigators sought to determine the effect HDL-C subparticles HDL2-C and HDL3-C have on assessing CAD severity in patients who receive statin therapy.

Comorbid Metabolic Syndrome, Psoriatic Arthritis Linked to Reduced Health-Related Quality of Life

By

Sheila Jacobs

Patients with plaque psoriasis have a reduced health-related quality of life, mainly in terms of emotional aspects.

Cardiovascular Comorbidity Screening Should Be Conducted in COPD With Obesity

By

Sheila Jacobs

Hypertension and diabetes are especially prevalent comorbidities in obese patients with chronic obstructive pulmonary disease.

Linagliptin and Cardiovascular Events in Patients With Type 2 Diabetes

By

Frank J. Connor

Investigators evaluated the effect of linagliptin vs placebo on cardiovascular and kidney disease outcomes in patients with T2D at high risk for cardiovascular and renal events.